Tag results:

Oct4

The Combined Action of Esrrb and Nr5a2 Is Essential for Murine Naïve Pluripotency.

[Development] Investigators reported that the conjunct activity of two orphan nuclear receptors, Esrrb and Nr5a2, paralleled the importance of that of Oct4 and Sox2 in naïve ESCs.

Comparative Analysis of Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells and Umbilical Cord Mesenchymal Stem Cells

[Journal of Cellular and Molecular Medicine] Researchers compared the therapeutic potential of induced pluripotent stem cells differentiation into MSCs generated from urinary epithelial cells with the available umbilical cord MSCs.

Dissecting OCT4 Defines the Role of Nucleosome Binding in Pluripotency

[Nature Cell Biology] Scientists systematically dissected OCT4 to show that nucleosome binding was encoded within the DNA-binding domain and yet could be uncoupled from free-DNA binding. They found that stable interactions between OCT4 and nucleosomes were continuously required for maintaining the accessibility of pluripotency enhancers in stem cells.

Development and In Vitro Characterization of an Induced Pluripotent Stem Cell Model of Ovarian Cancer

[International Journal of Biochemistry & Cell Biology] An ovarian cancer cell line, PEO4, was reprogrammed into iPSCs using the classical four factors OCT4, SOX2, KLF4 and MYC (OSKM) using lentivirus transduction.

Development and In Vitro Characterisation of an Induced Pluripotent Stem Cell Model of Ovarian Cancer

[International Journal of Biochemistry & Cell Biology] An ovarian cancer cell line, PEO4, was initially reprogrammed into induced pluripotent stem cells using the classical four factors OCT4, SOX2, KLF4 and MYC using lentivirus transduction.

Episomal Vector Reprogramming of Human Umbilical Cord Blood Natural Killer Cells to an Induced Pluripotent Stem Cell Line MUSIi013-A

[Stem Cell Research] Natural killer cells were isolated from human umbilical cord blood from a healthy newborn and reprogrammed by episomal vectors carrying reprograming factors L-MYC, LIN28, OCT4, SOX2, KLF4, EBNA-1, and shRNA against p53 delivered using nucleofection.

Popular